Recent News for CNAT - Conatus Pharmaceuticals Inc.

Date Title
Jan 8 50 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Dec 2 Intercept (ICPT) Gains 7.5% YTD on Progress in NASH Space
Nov 29 NASH Scorecard Year to Date: The Winners and the Losers
Nov 18 Conatus Pharmaceuticals Appoints Kathy Scott as Independent Board Member
Nov 6 Conatus Pharmaceuticals (CNAT) Reports Q3 Loss, Misses Revenue Estimates
Nov 5 Conatus Pharmaceuticals EPS beats by $0.02, misses on revenue
Nov 5 Conatus Pharmaceuticals Reports Third Quarter 2019 Financial Results
Nov 3 Is Conatus Pharmaceuticals Inc.'s (NASDAQ:CNAT) CEO Paid Enough Relative To Peers?
Oct 31 Conatus Pharmaceuticals (CNAT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Oct 11 Phibro (PAHC) Suffers Dismal Segmental Sales, Margin Woes
Oct 11 Penumbra Enrolls First Patient for Study on Coronary Vessels
Sep 19 How Long Will Conatus Pharmaceuticals Inc.'s (NASDAQ:CNAT) Cash Last?
Sep 10 Top Ranked Momentum Stocks to Buy for September 10th
Aug 19 Conatus (CNAT) Upgraded to Strong Buy: Here's What You Should Know
Aug 7 Conatus (CNAT) Beats on Q2 Earnings, Stops Emricasan Studies
Aug 6 Conatus Pharmaceuticals (CNAT) Reports Q2 Loss, Tops Revenue Estimates
Aug 6 Conatus Pharmaceuticals beats on revenue
Aug 6 Conatus Pharmaceuticals Reports Second Quarter 2019 Financial Results and Program Updates
Aug 3 The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts
Aug 3 29 Healthcare Stocks Moving In Friday's After-Market Session
Jul 31 Will Conatus Pharmaceuticals (CNAT) Report Negative Q2 Earnings? What You Should Know
Jul 27 The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Jul 26 30 Healthcare Stocks Moving In Thursday's After-Market Session
Jul 25 Investors Who Bought Conatus Pharmaceuticals (NASDAQ:CNAT) Shares Five Years Ago Are Now Down 96%

Back to the Main CNAT Page...